Development and External Validation of a Multiparametric Magnetic Resonance Imaging and International Society of Urological Pathology Based Add-On Prediction Tool to Identify Prostate Cancer Candidates for Pelvic Lymph Node Dissection.


Journal

The Journal of urology
ISSN: 1527-3792
Titre abrégé: J Urol
Pays: United States
ID NLM: 0376374

Informations de publication

Date de publication:
Apr 2020
Historique:
pubmed: 14 11 2019
medline: 21 4 2020
entrez: 14 11 2019
Statut: ppublish

Résumé

We sought to expand current prediction tools for lymph node invasion in patients with prostate cancer using current state-of-the-art available tumor information, including multiparametric magnetic resonance imaging based tumor stage and detailed biopsy information. We selected patients with prostate cancer for study who had available registered information on ISUP (International Society of Urological Pathology) based biopsy grading and multiparametric magnetic resonance imaging, and who had undergone radical prostatectomy with extended pelvic lymph node dissection. We developed a lymph node invasion prediction tool in 420 patients and externally validated it in 187. A concordance index was estimated to quantify the discriminative performance of the model. In the development cohort a median of 21 lymph nodes were removed per patient and 71 patients (16.9%) were diagnosed with lymph node invasion. Statistically significant predictors of lymph node invasion were the initial prostate specific antigen value, multiparametric magnetic resonance imaging based T stage, maximum tumor length in 1 core in mm and ISUP grade group corresponding to the maximum tumor involvement in 1 core. The predictive accuracy of this lymph node invasion prediction tool was 79.7% after fivefold internal cross validation and 72.5% after external validation. We report a contemporary, externally validated prediction tool for lymph node invasion in patients with prostate cancer. This prediction tool is a response to the paradigm shift from systematic to targeted biopsies by incorporating additional core specific biopsy information instead of the percent of positive cores. This new tool will also overcome stage migration, which is a potential risk when multiparametric magnetic resonance imaging information is used in digital rectal examination based nomograms.

Identifiants

pubmed: 31718396
doi: 10.1097/JU.0000000000000652
doi:

Substances chimiques

KLK3 protein, human EC 3.4.21.-
Kallikreins EC 3.4.21.-
Prostate-Specific Antigen EC 3.4.21.77

Types de publication

Journal Article Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

713-718

Auteurs

Cédric Draulans (C)

Department of Radiation Oncology, University Hospitals Leuven, Leuven, Belgium.
Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium.

Wouter Everaerts (W)

Department of Urology, University Hospitals Leuven, Leuven, Belgium.
Department of Development and Regeneration, Katholieke Universiteit Leuven, Leuven, Belgium.

Sofie Isebaert (S)

Department of Radiation Oncology, University Hospitals Leuven, Leuven, Belgium.
Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium.

Siska Van Bruwaene (S)

Department of Urology, AZ Groeninge Hospital, Kortrijk, Belgium.

Thomas Gevaert (T)

Department of Development and Regeneration, Katholieke Universiteit Leuven, Leuven, Belgium.

Raymond Oyen (R)

Department of Radiology, University Hospitals Leuven, Leuven, Belgium.
Department of Imaging and Pathology, Katholieke Universiteit Leuven, Leuven, Belgium.

Steven Joniau (S)

Department of Urology, University Hospitals Leuven, Leuven, Belgium.
Department of Development and Regeneration, Katholieke Universiteit Leuven, Leuven, Belgium.

Evelyne Lerut (E)

Department of Pathology, University Hospitals Leuven, Leuven, Belgium.
Department of Imaging and Pathology, Katholieke Universiteit Leuven, Leuven, Belgium.

Liesbeth De Wever (L)

Department of Radiology, University Hospitals Leuven, Leuven, Belgium.

Annouschka Laenen (A)

Leuven Biostatistics and Statistical Bioinformatics Center, Katholieke Universiteit Leuven, Leuven, Belgium.

Birgit Weynand (B)

Department of Pathology, University Hospitals Leuven, Leuven, Belgium.
Department of Imaging and Pathology, Katholieke Universiteit Leuven, Leuven, Belgium.

Gilles Defraene (G)

Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium.

Els Vanhoutte (E)

Department of Radiology, University Hospitals Leuven, Leuven, Belgium.

Gert De Meerleer (G)

Department of Radiation Oncology, University Hospitals Leuven, Leuven, Belgium.
Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium.

Karin Haustermans (K)

Department of Radiation Oncology, University Hospitals Leuven, Leuven, Belgium.
Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH